What sector does Humana belong to?

Humana operates in the Health Care sector, specifically the Managed Health Care industry, and is listed on the US markets.

What is the current share price of HUM?

As of the latest available quote, HUM traded at $409.80. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of HUM?

Humana has a price-to-earnings (P/E) ratio of about 38.77. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of HUM?

The market capitalisation of Humana is approximately $49.48B.

Is Humana profitable?

For its latest reported financial year, Humana recorded a net profit margin of about 20.37%.

Does HUM pay a dividend?

Humana currently has a dividend yield of about 0.88%.

What is the return on equity (ROE) of HUM?

Humana has a return on equity (ROE) of about 6.39%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of HUM?

Over the past 52 weeks, HUM has traded between a low of $163.11 and a high of $428.88.

Humana

HUM US Health Care Managed Health Care

S&P 500

$409.80

+2.26%

Delayed · cached 15 min

Fair value analysis

HUM

Humana

$409.80

Close used for this calculation

$201.16Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

42/100

Profitability17/25

Returns3/25

Balance Sheet18/25

Efficiency4/25

Growth1/25

Average

Quality radar

Consensus fair value

$201.16

Above FV

▼ -50.9% against the close used

Model range $26.37 – $251.88

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$26.37Fair value$201.16Bull$251.88

FairClose

52-week traded range

52W low $163.6752W high $409.80

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Humana closed at $409.80, 103.7% above the consensus fair value of $201.16 drawn from 8 valuation models.

Financial DNA score 42/100 — Average. P/E of 41.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$42.85

-89.5%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=2.7%, r=10%, tg=3%, n=10yr

Graham Number

$184.69

-54.9%

√(22.5 × EPS × BVPS)

EPS=9.84, BVPS=154.06 · outside Graham range (P/E 41.7, P/B 2.7) — asset-light, treat as a rough floor

P/E Fair Value

$196.80

-52.0%

EPS × 20x (sector P/E)

EPS=9.84, Sector P/E=20x

Peter Lynch (PEG)

$26.37

-93.6%

EPS × Growth% (PEG = 1 is fair)

EPS=9.84, g=2.7%

EV/EBITDA

$251.88

-38.5%

(EBITDA × 11.3x − Net Debt) ÷ Shares

EBITDA=3.4B

Book Value (P/B)

$74.61

-81.8%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=154.06, ROE=6.4%, g=3%, r=10%

Reverse DCF

$409.80

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 17% | Historical: 2.7%

Margin of Safety

$106.09

-74.1%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=141.45, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer